Manufacturing of a colon-delivery formulation platform of metronidazole for treating clostridium difficile infection
Ended Awarded Last action
- Contract number
- 75N93020F00006
- Awardee
-
Sri International UEI SRG2J1WS9X63
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $2,123,458
Award facts
- Contract value 100% obligated
- $2,123,458.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Menlo Park, CA 94025, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Change Order | $432,944 | |
| Other Administrative Action | $0 | |
| Definitize Change Order | $0 | |
| Change Order | $115,067 | |
| Other Administrative Action | $0 | |
| Original award | $1,575,447 |
About this award
Sri International has been awarded a delivery order against the Nonclinical Services for Development of Interventional Agents master IDIQ contract by the National Institutes of Health National Institute of Allergy and Infectious Diseases. Valued at $2,123,458, this cost-plus-fixed-fee contract calls for Sri International to develop a colon-delivery formulation platform of metronidazole to treat Clostridium difficile infection. Work will be performed in West Menlo Park, California over a three-year period ending January 2025. The award supports the National Institute of Allergy and Infectious Diseases' efforts to develop new treatment options for this potentially life-threatening infection.
Quick answers
Who was awarded contract 75N93020F00006?
75N93020F00006 was awarded to Sri International by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 2, 2020.
How much is contract 75N93020F00006 worth?
The government has obligated $2,123,458 on 75N93020F00006.
Is contract 75N93020F00006 an order under another contract?
Yes. 75N93020F00006 is a delivery order under 75N93018D00001, an indefinite delivery contract, on Nonclinical Services for Development of Interventional Agents.
Was contract 75N93020F00006 competed?
The extent of competition for 75N93020F00006 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award